New study tests smarter smoking cessation strategies
NCT ID NCT04188873
First seen Jun 23, 2026
Summary
This study tested different ways to help daily smokers quit by comparing two medications (varenicline and nicotine patches/lozenges), how long to take them before quitting, how long to continue after quitting, and the level of counseling. Over 500 smokers from primary care participated. The goal was to find the most effective and cost-efficient treatment plan to achieve long-term abstinence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NICOTINE DEPENDENCE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UW Center for Tobacco Research and Intervention
Milwaukee, Wisconsin, 53233, United States
-
University of Wisconsin Center for Tobacco Research and Intervention
Madison, Wisconsin, 53711, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
varenicline and nicotine replacement therapy (patch and lozenge)
What this could lead to
If successful, this could identify the most effective combination of medication and counseling to help smokers quit long-term.
What could go wrong
This is a completed Phase 4 trial, so results are available but may not apply to all smokers. Side effects from medications are possible.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.